Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    8630372 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rilonacept to Improve Artery Function in Patients With Atherosclerosis
Conditions: Coronary Artery Disease;   Atherosclerosis;   Inflammation;   Endothelial Dysfunction
Interventions: Drug: Rilonacept;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.